Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

According to NHS GP Dr Sooj, if you have asthma or chronic obstructive pulmonary disease (COPD) you should think twice before ...

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 70+ ...

A recent study published in The New England Journal of Medicine has found that elinzanetant, a therapy targeted at neurokinin ...

† Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States ‡ Lilly Research Center, A Division of Eli Lilly and Company, Erl ...

and 666 events in those prescribed selective beta-blockers. Median follow-up was 2.3 years (IQR: 0.9–4.3) for non-selective beta-blockers and 1.9 years (IQR: 0.8–3.6) for selective compounds ...

There is close phylogenetic homology between receptors for glucocorticoids ... taking oral glucocorticoids of 1.50 in one study 22 and 2.56 in another study. 23 The eye: topical steroids can ...

Splitgate 2 is looking to change that, and today sees the start of its open beta which contains almost everything you're going to get in the full game later this year. Plus, the Splitgate 2 open ...